You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Pericarditis Drugs Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

Pericarditis is the inflammation of the pericardium. Pericardium is two thin layers of a sac like structure of tissues that surrounds the heart. The pericardium holds the heart in place and helps it work. It is a small amount of fluid that keeps both the layers separated from each other so that there is no friction between the layers. Pericarditis often causes chest pain and other symptoms too. The harsh chest pain associated with pericardium occurs when the layers of the pericardium rub against each other. Pericarditis usually begins suddenly but does not last for long.When symptoms related to pericarditis develops more gradually or persists, it is considered as chronic pericarditis. Most cases of pericarditis are mild and usually improve on their own. The common symptoms related to pericarditis include cough; leg or abdominal swelling; low-grade fever; heart palpitations; shortness of breath when reclining; an overall sense of weakness, feeling sick or fatigue; and sharp, piercing chest pain. Pericarditis can be diagnosed with the help of electrocardiogram results, echocardiogram, physical examination, cardiac MRI, and reported symptoms.
Market Analysis and Insights: Global Pericarditis Drugs Market
The global Pericarditis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pericarditis Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pericarditis Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pericarditis Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pericarditis Drugs market.
Pericarditis Drugs Breakdown Data by Type
By Drug
Nonsteroidal Anti-Inflammatory Agents (NSAIDs)
Colchicine
Steroids
Antibiotics
Others
By Route of Administration
Intravenous
Oral
Others
By Disease
Acute Pericarditis
Chronic Pericarditis
Recurrent Pericarditis
Idiopathic Pericarditis
Pericarditis Drugs Breakdown Data by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Based on regional and country-level analysis, the Pericarditis Drugs market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Pericarditis Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
Pfizer Inc
Sanofi
Novartis
Bayer
AstraZeneca
Takeda Pharmaceuticals Industries Ltd
Teva Pharmaceutical Industries Ltd
Merck & Co., Inc
Abbive(Allergan)
Hikma Pharmaceuticals PLC
Avion Pharmaceuticals LLC
Dr. Reddy’s Laboratories Ltd
Viatris
Amneal Pharmaceuticals LLC
Sun Pharmaceuticals Industries Ltd
Lupin
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pericarditis Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nonsteroidal Anti-Inflammatory Agents (NSAIDs)
1.2.3 Colchicine
1.2.4 Steroids
1.2.5 Antibiotics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Pericarditis Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pericarditis Drugs Market Perspective (2016-2027)
2.2 Pericarditis Drugs Growth Trends by Regions
2.2.1 Pericarditis Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pericarditis Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Pericarditis Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Pericarditis Drugs Industry Dynamic
2.3.1 Pericarditis Drugs Market Trends
2.3.2 Pericarditis Drugs Market Drivers
2.3.3 Pericarditis Drugs Market Challenges
2.3.4 Pericarditis Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pericarditis Drugs Players by Revenue
3.1.1 Global Top Pericarditis Drugs Players by Revenue (2016-2021)
3.1.2 Global Pericarditis Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Pericarditis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pericarditis Drugs Revenue
3.4 Global Pericarditis Drugs Market Concentration Ratio
3.4.1 Global Pericarditis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pericarditis Drugs Revenue in 2020
3.5 Pericarditis Drugs Key Players Head office and Area Served
3.6 Key Players Pericarditis Drugs Product Solution and Service
3.7 Date of Enter into Pericarditis Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pericarditis Drugs Breakdown Data by Type
4.1 Global Pericarditis Drugs Historic Market Size by Type (2016-2021)
4.2 Global Pericarditis Drugs Forecasted Market Size by Type (2022-2027)

5 Pericarditis Drugs Breakdown Data by Application
5.1 Global Pericarditis Drugs Historic Market Size by Application (2016-2021)
5.2 Global Pericarditis Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pericarditis Drugs Market Size (2016-2027)
6.2 North America Pericarditis Drugs Market Size by Type
6.2.1 North America Pericarditis Drugs Market Size by Type (2016-2021)
6.2.2 North America Pericarditis Drugs Market Size by Type (2022-2027)
6.2.3 North America Pericarditis Drugs Market Size by Type (2016-2027)
6.3 North America Pericarditis Drugs Market Size by Application
6.3.1 North America Pericarditis Drugs Market Size by Application (2016-2021)
6.3.2 North America Pericarditis Drugs Market Size by Application (2022-2027)
6.3.3 North America Pericarditis Drugs Market Size by Application (2016-2027)
6.4 North America Pericarditis Drugs Market Size by Country
6.4.1 North America Pericarditis Drugs Market Size by Country (2016-2021)
6.4.2 North America Pericarditis Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pericarditis Drugs Market Size (2016-2027)
7.2 Europe Pericarditis Drugs Market Size by Type
7.2.1 Europe Pericarditis Drugs Market Size by Type (2016-2021)
7.2.2 Europe Pericarditis Drugs Market Size by Type (2022-2027)
7.2.3 Europe Pericarditis Drugs Market Size by Type (2016-2027)
7.3 Europe Pericarditis Drugs Market Size by Application
7.3.1 Europe Pericarditis Drugs Market Size by Application (2016-2021)
7.3.2 Europe Pericarditis Drugs Market Size by Application (2022-2027)
7.3.3 Europe Pericarditis Drugs Market Size by Application (2016-2027)
7.4 Europe Pericarditis Drugs Market Size by Country
7.4.1 Europe Pericarditis Drugs Market Size by Country (2016-2021)
7.4.2 Europe Pericarditis Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pericarditis Drugs Market Size (2016-2027)
8.2 Asia-Pacific Pericarditis Drugs Market Size by Type
8.2.1 Asia-Pacific Pericarditis Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pericarditis Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pericarditis Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Pericarditis Drugs Market Size by Application
8.3.1 Asia-Pacific Pericarditis Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pericarditis Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pericarditis Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Pericarditis Drugs Market Size by Region
8.4.1 Asia-Pacific Pericarditis Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pericarditis Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pericarditis Drugs Market Size (2016-2027)
9.2 Latin America Pericarditis Drugs Market Size by Type
9.2.1 Latin America Pericarditis Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Pericarditis Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Pericarditis Drugs Market Size by Type (2016-2027)
9.3 Latin America Pericarditis Drugs Market Size by Application
9.3.1 Latin America Pericarditis Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Pericarditis Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Pericarditis Drugs Market Size by Application (2016-2027)
9.4 Latin America Pericarditis Drugs Market Size by Country
9.4.1 Latin America Pericarditis Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Pericarditis Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pericarditis Drugs Market Size (2016-2027)
10.2 Middle East & Africa Pericarditis Drugs Market Size by Type
10.2.1 Middle East & Africa Pericarditis Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pericarditis Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pericarditis Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Pericarditis Drugs Market Size by Application
10.3.1 Middle East & Africa Pericarditis Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pericarditis Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pericarditis Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Pericarditis Drugs Market Size by Country
10.4.1 Middle East & Africa Pericarditis Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pericarditis Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Company Details
11.1.2 Pfizer Inc Business Overview
11.1.3 Pfizer Inc Pericarditis Drugs Introduction
11.1.4 Pfizer Inc Revenue in Pericarditis Drugs Business (2016-2021)
11.1.5 Pfizer Inc Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Pericarditis Drugs Introduction
11.2.4 Sanofi Revenue in Pericarditis Drugs Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Pericarditis Drugs Introduction
11.3.4 Novartis Revenue in Pericarditis Drugs Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Pericarditis Drugs Introduction
11.4.4 Bayer Revenue in Pericarditis Drugs Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Pericarditis Drugs Introduction
11.5.4 AstraZeneca Revenue in Pericarditis Drugs Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 Takeda Pharmaceuticals Industries Ltd
11.6.1 Takeda Pharmaceuticals Industries Ltd Company Details
11.6.2 Takeda Pharmaceuticals Industries Ltd Business Overview
11.6.3 Takeda Pharmaceuticals Industries Ltd Pericarditis Drugs Introduction
11.6.4 Takeda Pharmaceuticals Industries Ltd Revenue in Pericarditis Drugs Business (2016-2021)
11.6.5 Takeda Pharmaceuticals Industries Ltd Recent Development
11.7 Teva Pharmaceutical Industries Ltd
11.7.1 Teva Pharmaceutical Industries Ltd Company Details
11.7.2 Teva Pharmaceutical Industries Ltd Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd Pericarditis Drugs Introduction
11.7.4 Teva Pharmaceutical Industries Ltd Revenue in Pericarditis Drugs Business (2016-2021)
11.7.5 Teva Pharmaceutical Industries Ltd Recent Development
11.8 Merck & Co., Inc
11.8.1 Merck & Co., Inc Company Details
11.8.2 Merck & Co., Inc Business Overview
11.8.3 Merck & Co., Inc Pericarditis Drugs Introduction
11.8.4 Merck & Co., Inc Revenue in Pericarditis Drugs Business (2016-2021)
11.8.5 Merck & Co., Inc Recent Development
11.9 Abbive(Allergan)
11.9.1 Abbive(Allergan) Company Details
11.9.2 Abbive(Allergan) Business Overview
11.9.3 Abbive(Allergan) Pericarditis Drugs Introduction
11.9.4 Abbive(Allergan) Revenue in Pericarditis Drugs Business (2016-2021)
11.9.5 Abbive(Allergan) Recent Development
11.10 Hikma Pharmaceuticals PLC
11.10.1 Hikma Pharmaceuticals PLC Company Details
11.10.2 Hikma Pharmaceuticals PLC Business Overview
11.10.3 Hikma Pharmaceuticals PLC Pericarditis Drugs Introduction
11.10.4 Hikma Pharmaceuticals PLC Revenue in Pericarditis Drugs Business (2016-2021)
11.10.5 Hikma Pharmaceuticals PLC Recent Development
11.11 Avion Pharmaceuticals LLC
11.11.1 Avion Pharmaceuticals LLC Company Details
11.11.2 Avion Pharmaceuticals LLC Business Overview
11.11.3 Avion Pharmaceuticals LLC Pericarditis Drugs Introduction
11.11.4 Avion Pharmaceuticals LLC Revenue in Pericarditis Drugs Business (2016-2021)
11.11.5 Avion Pharmaceuticals LLC Recent Development
11.12 Dr. Reddy’s Laboratories Ltd
11.12.1 Dr. Reddy’s Laboratories Ltd Company Details
11.12.2 Dr. Reddy’s Laboratories Ltd Business Overview
11.12.3 Dr. Reddy’s Laboratories Ltd Pericarditis Drugs Introduction
11.12.4 Dr. Reddy’s Laboratories Ltd Revenue in Pericarditis Drugs Business (2016-2021)
11.12.5 Dr. Reddy’s Laboratories Ltd Recent Development
11.13 Viatris
11.13.1 Viatris Company Details
11.13.2 Viatris Business Overview
11.13.3 Viatris Pericarditis Drugs Introduction
11.13.4 Viatris Revenue in Pericarditis Drugs Business (2016-2021)
11.13.5 Viatris Recent Development
11.14 Amneal Pharmaceuticals LLC
11.14.1 Amneal Pharmaceuticals LLC Company Details
11.14.2 Amneal Pharmaceuticals LLC Business Overview
11.14.3 Amneal Pharmaceuticals LLC Pericarditis Drugs Introduction
11.14.4 Amneal Pharmaceuticals LLC Revenue in Pericarditis Drugs Business (2016-2021)
11.14.5 Amneal Pharmaceuticals LLC Recent Development
11.15 Sun Pharmaceuticals Industries Ltd
11.15.1 Sun Pharmaceuticals Industries Ltd Company Details
11.15.2 Sun Pharmaceuticals Industries Ltd Business Overview
11.15.3 Sun Pharmaceuticals Industries Ltd Pericarditis Drugs Introduction
11.15.4 Sun Pharmaceuticals Industries Ltd Revenue in Pericarditis Drugs Business (2016-2021)
11.15.5 Sun Pharmaceuticals Industries Ltd Recent Development
11.16 Lupin
11.16.1 Lupin Company Details
11.16.2 Lupin Business Overview
11.16.3 Lupin Pericarditis Drugs Introduction
11.16.4 Lupin Revenue in Pericarditis Drugs Business (2016-2021)
11.16.5 Lupin Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 100